50-155-7746

CtIP Polyclonal Antibody, Bethyl Laboratories

Manufacturer: Bethyl Laboratories, Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-155-7746-Each-of-1 In Stock ₹ 12,384.35

50-155-7746 - Each of 1

₹ 12,384.35

In Stock

Quantity

1

Base Price: ₹ 12,384.35

GST (18%): ₹ 2,229.183

Total Price: ₹ 14,613.533

Antigen

CtIP

Classification

Polyclonal

Formulation

TBS with 0.1% BSA and 0.09% sodium azide

Gene Accession No.

Q80YR6, Q99708

Gene Symbols

Rbbp8

Immunogen

Between 850 and C-term

Quantity

20 μL

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Applications

Western Blot

Conjugate

Unconjugated

Gene

RBBP8

Gene Alias

CTIP, RIM

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

225182, 5932

Content And Storage

4° C

Form

Liquid

Related Products

Img

Bethyl Laboratories, Inc

50-155-7333

--

Img

Bethyl Laboratories, Inc

50-155-6920

--

Img

Bethyl Laboratories, Inc

50-155-6923

--

Img

Bethyl Laboratories, Inc

50-155-6793

--

Img

Bethyl Laboratories, Inc

50-155-6978

--

Img

Bethyl Laboratories, Inc

50-155-7837

--

Img

Bethyl Laboratories, Inc

50-155-7462

--

Img

Bethyl Laboratories, Inc

50-155-7769

--

Description

  • The recommended shelf life for this product is 1 year from date of receipt
  • CtIP, a 125 kD protein, was originally found interacting with a transcription repressor, CtBP, through the PLDLS motif (CtBP-Interacting Protein) thus suggested a role in transcription
  • Studies have shown that CtIP also interacts with BRCA1 protein through the c-terminus BRCT domains also suggested that CtIP is a potential tumor suppressor
  • This CtIP-BRCA1 interaction can be disruppted by DNA damaging agents including UV or gamma-irradiation
  • Li et al (Nature 406, 210 - 215 (2000)) have shown that ATM phosphorylates CtIP at serine residues 664 and 745, and mutation of these sites abrogates the dissociation of BRCA1 from CtIP, resulting in persistent repression of BRCA1-dependent induction of GADD45 upon ionizing radiation.